Sponsors and Exhibitors

BioIVT enables smarter science and accelerates medical breakthroughs by delivering high-quality personalized biospecimen solutions and research services to life science and diagnostic industries. Recognized as an industry leader, we specialize in control and disease state samples including human and animal tissues or preparations, cell and gene therapy products, blood, and other biofluids, as well as ADME contract research services from standalone bioanalytical support through tiered in vitro studies with submission-ready reports to customized consulting.

By combining our technical expertise, exceptional customer service, and unmatched access to biological specimens, BioIVT serves the research community as a trusted partner in ELEVATING SCIENCE®.

BioIVT

We are passionately committed to our role in enhancing the quality of human lives. We are a unique, world-class, globally integrated testing platform supporting the entire continuum of the drug development journey. From discovery through preclinical to clinical and beyond, we enable scientists to transform their ideas into healthcare products that ultimately improve life.

We are dedicated to providing you and your program with the highest level of attention. Our subject matter experts (SMEs) are there with you every step of the way, to collaborate and work through the unique challenges of drug discovery and development.

WuXi AppTec

Discovery Life Sciences accelerates the discovery and development of new therapies and diagnostics by providing biopharma and diagnostic companies with the highest quality biospecimens, in vitro preclinical products, and cell & gene therapy starting materials coupled with specialty lab services that are grounded in science and offered at scale to support large scale clinical trials.

Discovery Life Sciences

Frontage Laboratories, Inc., is a global Contract Research Organization (CRO) which provides integrated, science-driven, product development services from drug discovery to late phase clinical process to enable biopharmaceutical companies to achieve their development goals.  Comprehensive services include drug metabolism and pharmacokinetics, analytical testing and formulation development, preclinical and clinical trial material manufacturing, bioanalysis, preclinical safety and toxicology assessment and early phase clinical studies. Frontage has enabled many biotechnology companies and leading pharmaceutical companies of varying sizes to advance a myriad of new molecules through development and to successfully file global regulatory submissions.

Frontage Laboratories

SCIEX is leading the way in advanced analytical solutions. Explore our innovative technologies and services at Sciex.com. Revolutionizing drug discovery, precision medicine, and toxicology research. Join us at ISSX 2023 to learn more about our cutting-edge solutions and drive scientific advancements together.

SCIEX

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

Charles River

Labcorp is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities.

LabCorp

For 25 years, Sai Life Sciences has been a trusted partner in bringing new medicines to life, fast. As a global Contract Research, Development & Manufacturing Organization (CRO-CDMO), Sai Life Sciences works with innovator biotech and pharma companies to accelerate the discovery, development and commercialization of complex small molecules. With 3000 employees across facilities in India, UK and USA, Sai supports innovators through journey from concept to commercialization, including exploratory biology, creative chemistry, DMPK, toxicology, developability & formulations, early phase development, process & analytical development, scale-up, tech transfer, clinical supplies and cGMP manufacturing. Taking a nimble and creative approach, Sai delivers high-quality, cost-effective solutions to accelerate the time to market.

Sai Life Sciences Ltd

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 100,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.

Thermo Fisher

Optibrium develops exceptional software and AI solutions that help scientists advance their discovery projects. Cutting-edge science, backed up by rigorous research, underpins their intuitive software for compound design, optimisation and data analysis. Optibrium's comprehensive in silico platform improves the speed, efficiency, and productivity of the discovery process and supports a worldwide customer base, including leading pharma, biotech, agrochemical and flavouring companies and not-for-profit and academic groups.

Optibrium was founded in 2009 and is headquartered in Cambridge, UK, with a US subsidiary, Optibrium Inc., based in Cambridge MA.

Optibrium

The Drug Development Solutions Center of Sekisui Medical started in 1965. We conduct more than 1000 various ADME studies annually and provide products to the clients across the world.

Our service offerings range from pharmacokinetic and pharmacological screening studies to OECD-GLP compliant toxicokinetics studies using validated analytical methods. The research facility maintains full AAALAC (The Association for Assessment and Accreditation of Laboratory Animal Care International) accreditation for the appropriate use of laboratory animals in accordance with international standards.

We utilize our advanced technological capabilities to provide comprehensive support to pharmaceutical companies, academia and institutions involved in drug development. With experiences and expertise gained over 50 years, we are committed to keep high quality science for the world health.

Sekisui Medical Co. Ltd.

Admescope is a preclinical contract research organization (CRO) providing tailor-made ADME-Tox (Absorption, Distribution, Metabolism, Excretion and Toxicity) services for drug discovery and development companies. Our unique expertise lies in drug metabolism, drug interactions, pharmacokinetics and quantitative bioanalysis, where we stand out with our innovative approach combined with the latest technology. Our services are available for all drug modalities, e.g., small molecules, peptides, oligonucleotides, antibodies and ADCs.

Since 2020, Admescope has been a part of Symeres, with the ability to provide medicinal chemistry and integrated drug discovery & development services through the Symeres organization.

ADEMSCOPE

AIM Research Company is an international leader of innovation in the pharmaceutical research sphere. Founded in 1998, we have been dedicated to creating the best solutions for online radioactivity detection and offline counting fraction collection. Our instruments offer cost-effective solutions with high reliability to companies and organizations worldwide.

AIM Research Company

Aliri is committed to solving industry challenges by bringing innovative bioanalytical and spatial solutions to biotech and pharma, as the complexity of the drug development landscape continues to rise. Our mission is to support our customers with bringing life-saving therapies to market with speed and agility. We are focused on providing pharma and biotech companies with bioanalytical lab, spatial bioanalysis, and spatial biology solutions that will bring unique, comprehensive data to enable strategic decision making for lead optimization and strengthen regulatory submissions.

Aliri Bioanalysis

"Aloka has contributed to the effective use of radiation in the fields of energy, medicine, research, and industry through its radiation measurement technology.

We have been supplying liquid scintillation counters for pharmaceutical development for over 50 years."

Alturas Analytics provides regulated and non-regulated bioanalytical LC-MS/MS and GC-MS/MS quantitation and PK/TK analysis from discovery through late phase clinical trials. With extensive expertise analyzing small chemical and biomolecules, oligonucleotides, and drug conjugates in all matrices, we deliver results on-time with scientific integrity that exceeds industry standards.

Alturas Analytics

Located in San Diego, California, AnaBios aims to establish the safety and efficacy of novel compounds through its advanced, human-focused translational technologies. AnaBios primarily focuses on areas of high, unmet medical need, including cardiac disease, lung disease, CNS disorders, pain and itch. As a preclinical CRO, AnaBios has the most extensive network of hospitals and transplant centers for obtaining human tissue samples from ethically consented donors for ex vivo analysis.

AnaBios

BioAgilytix is the trusted partner for bioanalytical services throughout every phase of the drug development process. As a leading global bioanalytical laboratory, the company provides established and emerging pharmaceutical and biotechnology organizations with pharmacokinetic (PK), immunogenicity, biomarker, and CMC bioanalytical testing services in a GxP environment. BioAgilytix maintains state-of-the-art laboratories in Durham, North Carolina; Boston, Massachusetts; San Diego, California; Melbourne and Brisbane, Australia; and Hamburg, Germany.

BioAgilytix | Global Leader for Bioanalytical Services

BioAgilytix

BioDuro-Sundia, an Advent International portfolio company is a trusted, leading contract research development, and manufacturing organization (CRDMO) for over 28 years. We provide our biotech and pharmaceutical partners with fully integrated services to support their efforts from target identification through to commercial drug product manufacturing. The company is based in the US with operations in China, totaling 2,000+ employees and 7 global sites across 6 cities. Core expertise includes small and large molecule discovery, development and scale-up, support for IND submission, and unique technology platforms such as bioavailability enhancement of insoluble compounds. The one-stop-shop operation helps biotech and pharma partners across the globe to significantly accelerate discovery and de-risk development to create higher value outcomes. We adhere to one global highest standard of compliance and business operation code. Science-driven, customer-oriented, flexible, peoplefocused culture enables us to provide top-tier integrated, fast and flexible tailored services to our customers to meet their unique needs and accelerate our development timeline.

BioDuro - Sundia

From Discovery to Manufacturing

Over the past twenty years, ChemPartner has evolved from the pure chemistry service provider to a CRO/CDMO research innovation engine with a broad portfolio of services spanning from discovery, development, and manufacturing in both small molecule and large molecule therapeutics.

ChemPartner

Under its business philosophy, "Innovation all for the patients," the Chugai Group aims to add exceptional value through the creation of innovative medical products and services for the benefit of the medical community and human health around the world.

Chugai Pharmaceutical

Curachem, established in 2009, is a global provider of radioisotope-labeled compounds. In 2016, we expanded our operations to include GMP facilities to better serve our clients. Our new R&D facilities are equipped to produce GMP-grade drug substances for human ADME studies, non-GMP APIs for animal ADME studies, and stable-labeled compounds for pharmaceutical and environmental applications. At the heart of Curachem's success are our exceptionally skilled synthetic chemists and our superior analytical capabilities.

Curachem

Ellegaard Bioresearch is a subsidiary of the Danish company Ellegaard Göttingen Minipigs A/S, which was founded to supply scientists in biomedical research with a better non-rodent animal model, with many similarities to humans, a high-quality health standard, but also small and easy to handle. Today, Göttingen Minipigs are fully recognized as an established animal model by all regulatory authorities worldwide. From our AAALAC accredited facility, we breed Göttingen Minipigs, Humanized IgG Göttingen Minipigs, and provide scientific research services to enable the development of safer and more effective medicines, all based on our core values: Animal welfare, Quality, Respect, and Collaboration.

Ellegaard BioResearch

Hypha Discovery is a CRO specializing in: - mg/g/kg scale synthesis of phase I and II drug metabolites using multiple chemical and biotransformation techniques. - Gut metabolite service using pooled human faecal samples. - Purification of metabolites from biological matrices such as plasma, urine, faeces, and provision of COAs. - Microgram-scale structure identification using 700MHz micro cryoprobe NMR.

Hypha Discovery

iBody provides both rabbit and human monoclonal antibody generating services to therapeutic, reagent, and diagnostic companies as well as academic laboratories.

iBody's unique "Ecobody" technology enables lightning-fast antibody expression and evaluation. Using its Ecobody technology, iBody can mine the desired monoclonal antibodies within just one month.

iBody's advantages are our focus on:

1. Generating difficult-to-generate monoclonal antibodies

2. Generating monoclonal antibodies with excellent properties

3. Providing complete customized service ranging from rabbit immunization to recombinant antibody preparation

Looking forward to having a productive discussion at the conference.

IBody Inc.

ICE Bioscience was founded in 2010 as an Innovative CRO+ Explorer company. We specialize in early drug discovery services, spanning from target validation to the identification of pre-clinical candidates.

Currently, ICE Bioscience offers a broad selection of off-the-shelf assays, including 100+ ion channels, 800+ Kinases/enzymes, 100+ GPCRs, and 40+ nuclear receptor assays, all accompanied by validation data and screening information. This comprehensive range of assays provides us with a competitive edge, as it covers a vast majority of druggable targets.

Our company has established multiple platforms, encompassing Protein Engineering, Cell Line Development, Target Based Assays, Safety Pharmacology, Translational Biology, DMPK, In Vivo Pharmacology and Biophysical Assays, enabling us to smoothly execute the DMTA cycle (Design-Make-Test-Analysis cycle) for innovative drug discovery in collaboration with our clients.

ICE Bioscience

At Inotiv, You Can Expect More for Drug Discovery and Development. Gain the insights you deserve to get the answers you need. Inotiv provides deep expertise and scientific capabilities across the discovery and continuum. We support our clients from the beginning of discovery, through investigational new drug (IND) and beyond, all with the aim of delivering a superlative experience. Combined with our long history and deep experience with supply of critical research models, including rodents, rabbits, and nonhuman primates, Inotiv is the right-sized CRO for your next project. With our dedication to attentive, decisive service, you can trust that every program is a priority. Benefit from our long and impeccable regulatory history, world-class team of scientists, and on-time quality data delivery.

Mission, Vision, and Values

We deliver exceptional products and services that allow for scientific continuity.

Our Mission

To deliver exceptional service and products to drive improved decision making, allowing accelerated goal attainment, while providing client-centric scientific continuity in an environment where people are valued and can succeed.

Our Vision

As a leading contract research organization (CRO), Inotiv supports discovery and nonclinical development through investigational new drug (IND) and beyond. By leveraging our deep expertise and scientific capabilities, we help you increase efficiency, improve data, and reduce the cost of taking new drugs to market. By providing critical research models and related services, we help researchers realize the full potential of their R&D projects, all while working together to build a healthier and safer world.

Our Core Values

Deliver Excellent Client Experiences

Provide Insightful Problem Solving

Always Do the Right Thing

Be Humbly Confident

Get It Done

Inotiv

Javelin Biotech makes an in vitro research platform using Human MPS or Organ-on-Chip technologies to improve mechanistic understanding of the interactions between drugs and human physiology, helping our customers develop safe and efficacious therapies better and faster. As therapeutic modalities increase, current preclinical testing models become inadequate. The lack of human-specificity of animal models and the limited complexity of current in vitro models result in an increase to preclinical drug discovery costs and risk of clinical attritions.

Javelin human tissue chips bring both human complexity and specificity for acute and chronic drug studies. The chips generate longitudinal, high-content, and human-relevant data. Javelin AI-enabled digital twin technology analyzes multi-modal chip data and translates to human responses to design better medicines faster. This is Drug Discovery. Humanized.

Javelin Biotech

LabLogic Systems, Inc. is a leading provider of instruments and software for measurement and analysis of radioisotopes used in pharmaceutical, academic, nuclear medicine and research laboratories. Our systems include radiochromatography detectors and software for HPLC and TLC, liquid scintillation and gamma counters, radiation monitors, and microplate readers.

In addition to instruments LabLogic produce a range of specialist applications software including Laboratory Information Management Systems for ADME studies and PET production.

LabLogic Systems Inc.

LifeNet Health LifeSciences gives healing every advantage by providing research solutions that empower groundbreaking discoveries around the world. Our goal is to improve health and safety for humankind by providing all-human cells, in vitro physiological systems, biospecimens for research, and cytotoxicity services. We support scientists in the pharmaceutical, biotech, agriscience, food safety, and cosmetic industries.

LifeNet Health

Medicilon offers fully integrated pharmaceutical services for the global scientific community. We focus on providing an exceptional client-centered experience and advancing the drug discovery process.

Since the founding of our company in 2004, our integrated services across biology, chemistry and preclinical services are uniquely designed to help clients developing their research and discovery programs from the initial idea stage to the IND filing phase.

Our headquarters is located in Zhangjiang High-Tech Park in Shanghai, China, with an additional facility in Chuansha Economic Park, Shanghai, China. We occupy over 400,000 sq. ft. in lab space and have over 1,500 employees cross biology, chemistry and preclinical research. Over 50% of our employees have M.S. and Ph. D., over 10% of them have foreign education and/or working experiences.

Medicilon has been recognized as one of the top drug discovery contract research organizations (CRO) in China and is managed by a team of scientists with a wealth of experience in US-based pharmaceutical and biotechnology companies. As our areas of expertise and service capabilities continue to expand, more and more pharmaceutical and biotechnology companies have taken advantage of our integrated drug discovery and development services.

Shanghai Medicilon

MIMETAS is a global leader in disease modeling using Organ-on-a-Chip technologies. Founded in 2013 in Leiden, the Netherlands, MIMETAS strives to contribute to ground-breaking therapies with their screenable, physiologically relevant human disease models. By combining technological strengths and expertise, MIMETAS establishes strong drug development partnerships with and offers services to global pharmaceutical companies to develop innovative therapies to target untreatable diseases.

MIMETAS

Organ Perfusion & Cellular Services provides primary human and animal cells for research.

Organ Perfusion & Cellular Services

PhoenixBio is a global leader in the development and distribution of high-quality human liver models for preclinical research. Our PXB-Mouse is a humanized liver mouse model with up to 98% human hepatocyte engraftment. PXB-cells are human hepatocytes freshly isolated from the PXB-mouse and are frequently applied for in vitro research. Due to their unique ability to deliver preclinical insights, PhoenixBio models accelerate pharmaceutical and chemical compound development by better predicting human outcomes.

PhoenixBio

Precision Quantomics is a leading provider of quantitative pharmacology research tools designed to accelerate safer drug development and precision medicine. Our innovative products and services focus on the quantification of drug metabolizing enzymes using advanced proteomics technologies. We offer targeted and global proteomics solutions, enabling precise protein quantification in complex biological matrices such as cell homogenates, tissues, and biofluids.

Our mission is to facilitate the development of safe, effective, and economical drugs through the provision of authenticated in vitro reagents and comprehensive consultancy services. We specialize in characterizing in vitro reagents for accurate in vitro to in vivo extrapolation (IVIVE) and physiologically-based pharmacokinetic (PBPK) modeling.

Precision Quantomics

IQVIA Laboratories (formerly Q2 Solution) is an industry leader in clinical trial laboratory services, offering drug development services to assist pharmaceutical companies in developing assays and validated bioanalytical methods to support candidate identification and characterization. With extensive expertise in discovery and LC-MS bioanalysis, our platforms enable various aspects of ADME and pharmacokinetic (PK) testing. Balancing the promise of emerging technologies with the current needs of our clients, IQVIA Laboratories excels at large-scale screening using in-house or client-customized protocols with rapid turnaround.

With bioanalytical labs in the United States and China, our team utilizes a harmonized approach to support all phases of global clinical trials. To meet significant demands, IQVIA Laboratories also has the bioanalytical capabilities to support the largest pharmaceutical, specialty, and biotechnology companies around the globe. By leveraging the clinical trial expertise of IQVIA, coupled with our vast laboratory network, we offer a comprehensive solution to support testing across the entire drug development continuum.

Q2 Solutions

QPS is a GLP/GCP-compliant full-service CRO delivering the highest grade of discovery, preclinical, and clinical drug development services. Since 1995, it has rapidly expanded from a bioanalysis shop to a full-service CRO with 1,200+ employees in the US, Europe, India, and Asia. Today, QPS offers expanded pharmaceutical contract R&D services with special expertise in Toxicology, Pharmacology, DMPK, Bioanalysis, Translational Medicine, Clinical Trials, and Clinical Research Services. QPS has CLIA-certified and GLP-compliant laboratories ready to fast-track Gene Therapy, RT-qPCR/QPCR, serological assays, and vaccine development programs. An award-winning leader focused on bioanalysis and clinical trials, QPS is known for proven quality standards, technical expertise, a flexible approach to research, client satisfaction, turnkey laboratories, and Phase I clinical facilities. To schedule an appointment, email us: info@qps.com

QPS Holdings

Quotient Sciences is a drug development and manufacturing accelerator providing integrated programs and tailored services across the entire development pathway. Cutting through silos across a range of drug development capabilities, we save precious time and money in getting drugs to patients. Everything we do for our customers is driven by an unswerving belief that ideas need to become solutions, molecules need to become cures, fast. Because humanity needs solutions, fast.

Quotient Sciences

SEP provides high quality, consolidated preclinical drug discovery and development solutions for pharmaceutical, biotechnology, and cosmetic/consumer care companies. Created to serve organizations that wish to outsource some or all of their drug discovery and development support activities, SEP's services range from initial consultation and customized study proposals/protocols, to full study execution, result interpretation and discussion, regulatory agency compliance reporting, and guidance on the path to drug approval. Studies are expertly designed to guide and enlighten the customer, and the company's experienced leadership and staff help advance client compounds and support informed decision-making through the regulatory process and product approval. We go beyond the talk.

SEP Scientific

SNBL is a full-service nonclinical CRO based in Japan.

Our mission is to free patients from suffering by supporting drug development and improving medical technology.

The nonclinical research division of SNBL is Japan’s largest and oldest nonclinical CRO. For over 65 years, we have balanced speed with superior quality, carrying out studies efficiently, accurately and in a timely manner, consistently exceeding our customers’ expectations.

At SNBL, we embrace the challenges of innovation, growth and development in order to provide a meaningful contribution to the well-being of all people.

SNBL

With more than 25 years of experience serving clients globally, Simulations Plus stands as a premier provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. Our comprehensive biosimulation solutions integrate artificial intelligence/machine learning (AI/ML), physiologically based pharmacokinetics (PBPK), quantitative systems pharmacology/toxicology (QSP/QST), and population PK/PD modeling approaches. We also deliver simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Our cutting-edge technology is licensed and utilized by leading pharmaceutical, biotechnology, and regulatory agencies worldwide.

We offer #1-ranked, easy-to-use software (GastroPlus®, ADMET Predictor®, DILIsym®, NAFLDsym®, MonolixSuite®, and more) to bridge data mining and compound library screening with QSAR models, PK/PD model development, and PBPK/TK modeling & simulation in animals and humans following administration around the body, and quantitative systems pharmacology approaches. Our clinical simulations and medical communications software platforms (Pro-ficiency Performance Management and Panorama) support our clients' study quality and communications through drug development, regulatory submission, approval, and commercialization.

Simulations Plus

Signatope is a specialised company focusing on protein quantification. The assays are designed to evaluate the potential of substances to induce enzymes and transporters involved in drug metabolism, particularly the quantification of Cytochrome P450 enzymes. Unlike traditional methods that rely on mRNA profiling, Signatope utilises protein-based assays, as protein levels have a higher predictive value for enzyme activity than mRNA levels.

SIGNATOPE

Step into the world of cutting-edge drug development with SPMED CO; Ltd., your premier destination for preclinical ADME/DMPK services and top-tier recombinant metabolism enzyme production. At SPMED, we're not just a service provider; we're your partners in innovation, dedicated to accelerating the journey from concept to cure.

With a focus on excellence and a passion for advancing pharmaceutical research, we offer a comprehensive suite of services tailored to meet your specific needs. From pharmacogenomics tests to the sale of high-quality pharmacogenomics kits, we provide the tools and expertise necessary to drive success in the ever-evolving landscape of drug discovery.

Join us at the international conference and discover how SPMED can elevate your research to new heights. Our team of experts will be on hand to showcase our latest advancements, share insights, and discuss how we can collaborate to unlock the potential of your projects. Don't miss this opportunity to connect with industry leaders and take your research to the next level with SPMED CO; Ltd.

SPMED

Symbiotic Research, LLC (SRL) is a life sciences contract research laboratory located in Mt. Olive, New Jersey. They specialize in Regulatory Sciences GLP studies and are fully compliant with EPA and FDA regulations. SRL offers a range of services including GLP metabolism, bioanalysis, residue analysis, formulations development and analysis, and Product Chemistry. SRL has a subsidiary called Genesis Midwest LLC (GML) which is an animal and poultry research lab based in state of Wisconsin. Together, SRL and GML provide C-14 radiolabeled metabolism and non-radiolabeled residue package studies to clients worldwide.

Symbiotic Research, LLC & Genesis Midwest, LLC

TNO, as a trusted, independent, and pioneering applied science and technology organisation, plays a multifaceted role. We innovate, investigate, and orchestrate, collaborating closely with partners. TNO works with public and private parties to create and implement innovative technologies that make the process of drug development - from laboratory to patient - more efficient. This will make it possible to cut development costs and to get drugs to patients sooner.

TNO

Since its establishment in 1940, TOKYO OHKA KOGYO CO., LTD. (TOK) has consistently pursued programs of research and development of superior new technologies and new technical methodologies based on the following management principles: “continue efforts to enhance technology,” “raise the quality levels of products,” “contribute to society” and “Create a frank and open-minded business culture” As we have pursued development of new technologies and new technical methodologies, we have not only paid attention to developing highly functional products with high-performance and developing the cost effective and efficient manufacturing process technologies, but we have also closely examined our products and manufacturing methods with careful consideration to their load on the environment.

We are determined to continue contributing to the creation of a harmonious and even more prosperous society in the future by providing the very best technologies and products, as demonstrated by our chemical products, including photoresist. At the same time, we will always promote our corporate activities with CSR (corporate social responsibilities) in our mind by being fully aware of the environmental, social, and economic aspect.

Tokyo Ohka Kogyo Co., Ltd.